kyvero
Market leaders

WAY

Waystar Holding Corp. (WAY)

Healthcare • Health Information Services

StockNasdaqGSUnited StatesUS9467841055

28.14 USD -2.43% today Updated 13 Nov 2026 10:19

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Waystar Holding Corp., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 10:19. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 17 Feb 2027 in 96 days · 16:00 · estimate 0.41
Last results 0.44 vs 0.41 estimated 02 Nov 2026 · Beat +8.0%
Beat the estimate 7 of 9 1 missed · 1 in line · 3 beats in a row
Average surprise +18.7% reported against the estimate, last 9 quarters

Earnings per share: estimate and reported

06 Nov 2024: estimate 0.11 06 Nov 2024: reported 0.14 11/24 18 Feb 2025: estimate 0.14 18 Feb 2025: reported 0.29 02/25 30 Apr 2025: estimate 0.32 30 Apr 2025: reported 0.32 04/25 30 Jul 2025: estimate 0.34 30 Jul 2025: reported 0.36 07/25 29 Oct 2025: estimate 0.35 29 Oct 2025: reported 0.37 10/25 17 Feb 2026: estimate 0.40 17 Feb 2026: reported 0.36 02/26 29 Apr 2026: estimate 0.39 29 Apr 2026: reported 0.42 04/26 29 Jul 2026: estimate 0.40 29 Jul 2026: reported 0.43 07/26 02 Nov 2026: estimate 0.41 02 Nov 2026: reported 0.44 11/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
17 Feb 2027 16:00 0.41 — — Upcoming
02 Nov 2026 16:00 0.41 0.44 +8.0% Beat
29 Jul 2026 16:00 0.40 0.43 +8.3% Beat
29 Apr 2026 16:00 0.39 0.42 +8.7% Beat
17 Feb 2026 06:00 0.40 0.36 -9.0% Miss
29 Oct 2025 16:00 0.35 0.37 +5.7% Beat
30 Jul 2025 16:00 0.34 0.36 +6.2% Beat
30 Apr 2025 16:00 0.32 0.32 +0.2% In line
18 Feb 2025 06:00 0.14 0.29 +108.8% Beat
06 Nov 2024 16:00 0.11 0.14 +31.2% Beat
07 Aug 2024 16:00 -0.02 — +75.3% —

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 1.1B +16.5% 112.1M 10.2% 0.61 +569.2% 283.2M
2024 943.5M +19.3% -19.1M -2.0% -0.13 +57.8% 142.5M
2023 791M +12.2% -51.3M -6.5% -0.31 +0.2% 29.9M
2022 704.9M — -51.5M -7.3% -0.31 — 85.2M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by week
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
09 Nov 2026 – 12 Nov 2026 In progress 28.39 29.67 27.60 28.14 -0.74% 5,262,600
02 Nov 2026 – 06 Nov 2026 27.88 30.23 24.10 28.35 +1.25% 13,746,200
26 Oct 2026 – 30 Oct 2026 28.60 29.20 27.58 28.00 -2.95% 7,120,100
19 Oct 2026 – 23 Oct 2026 27.18 29.25 27.05 28.85 +5.45% 10,164,500
12 Oct 2026 – 16 Oct 2026 26.97 29.09 25.97 27.36 +2.55% 12,910,400
05 Oct 2026 – 09 Oct 2026 25.03 26.76 24.63 26.68 +7.54% 10,668,800
28 Sep 2026 – 02 Oct 2026 24.70 26.55 24.44 24.81 +0.45% 9,586,600
21 Sep 2026 – 25 Sep 2026 25.94 26.28 24.33 24.70 -3.74% 7,343,100
14 Sep 2026 – 18 Sep 2026 23.89 27.28 23.66 25.66 +9.33% 17,276,800
08 Sep 2026 – 11 Sep 2026 25.00 25.04 22.96 23.47 -6.38% 5,637,300
118 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
28.84 USD
Market cap
5.4B
Exchange
NasdaqGS
Country
United States
Sector
Healthcare
Industry
Health Information Services
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 25.0 / 25
  • Revenue growth of 16.0% a year
Quality Return on equity, net margin and how stable the margins are. 5.3 / 25
  • ROE of 4%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 12.8 / 20
  • Net debt is 2.7× EBITDA
  • Free cash flow yield of 6.5%
Valuation Free cash flow yield and the P/E against its sector. 9.4 / 15
  • P/E 42.0 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 10.0 / 10
  • Analysts' target is +23% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 42× Weak 30.56×
P/E (forward) 14.91× Good 14.16×
Price / book 1.34× Good 3.5×
Price / sales 4.29× Fair 3.33×
EV / EBITDA 14.97× Fair 11.19×
Free cash flow yield 6.5% Good 2.1%
Quality
FigureValueReading Sector median
Gross margin 69.4% Good 54.9%
Operating margin 23.1% Good 5.8%
Net margin 10.7% Good 1.2%
Return on equity 3.7% Weak 4.4%
Return on assets 3.4% Fair 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year 16% Good 10.1%
Financial health
FigureValueReading Sector median
Debt / equity 0.37× Good 0.4×
Net debt / EBITDA 2.72× Fair 1.46×
Interest cover 3.22× Fair 2.17×
Current ratio 2.1× Good 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow WAY and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in